Pharma Co. Misled Investors On Depression Drug, Suit Says

By Sydney Price · February 10, 2025, 9:20 PM EST

Brain disease drugmaker Neumora Therapeutics Inc. has been hit with a proposed shareholder class action alleging that the company and its initial public offering underwriters failed to disclose prior to the...

To view the full article, register now.

Documents

Case Information

Case Title

Chang v. Neumora Therapeutics, Inc. et al

Case Number

1:25-cv-01072

Court

New York Southern

Nature of Suit

Securities/Commodities

Date Filed

February 06, 2025